172 related articles for article (PubMed ID: 33996552)
1. Prognostic Role of Blood Markers in Primary Central Nervous System Lymphoma Patients Treated With High-Dose Methotrexate-Based Therapy.
Luo Q; Yang C; Fu C; Wu W; Wei Y; Zou L
Front Oncol; 2021; 11():639644. PubMed ID: 33996552
[No Abstract] [Full Text] [Related]
2. Pretreatment Hemoglobin as an Independent Prognostic Factor in Primary Central Nervous System Lymphomas.
Le M; Garcilazo Y; Ibáñez-Juliá MJ; Younan N; Royer-Perron L; Benazra M; Mokhtari K; Houillier C; Hoang-Xuan K; Alentorn A
Oncologist; 2019 Sep; 24(9):e898-e904. PubMed ID: 30867243
[TBL] [Abstract][Full Text] [Related]
3. Complete Blood Count Score Model Predicts Inferior Prognosis in Primary Central Nervous System Lymphoma.
Feng Y; Liu Y; Zhong M; Wang L
Front Oncol; 2021; 11():618694. PubMed ID: 33842320
[TBL] [Abstract][Full Text] [Related]
4. Proposed new prognostic model using the systemic immune-inflammation index for primary central nervous system lymphoma: A prospective-retrospective multicohort analysis.
Li S; Xia Z; Cao J; Zhang J; Chen B; Chen T; Zhang X; Zhu W; Li D; Hua W; Mao Y
Front Immunol; 2022; 13():1039862. PubMed ID: 36439151
[TBL] [Abstract][Full Text] [Related]
5. A Novel Prognostic Marker for Primary CNS Lymphoma: Lactate Dehydrogenase-to-Lymphocyte Ratio Improves Stratification of Patients Within the Low and Intermediate MSKCC Risk Groups.
Gao Y; Wei L; Kim SJ; Wang L; He Y; Zheng Y; Bertero L; Pellerino A; Cassoni P; Tamagnone L; Theresa PK; Deutsch A; Zhan H; Lai J; Wang Y; You H
Front Oncol; 2021; 11():696147. PubMed ID: 34422649
[TBL] [Abstract][Full Text] [Related]
6. C-reactive protein levels, the prognostic nutritional index, and the lactate dehydrogenase-to-lymphocyte ratio are important prognostic factors in primary central nervous system lymphoma: a single-center study of 223 patients.
Zuo J; Lei T; Zhong S; Zhou J; Liu R; Wu C; Li S
Neurosurg Rev; 2023 Dec; 47(1):17. PubMed ID: 38112846
[TBL] [Abstract][Full Text] [Related]
7. Role of chemotherapy additional to high-dose methotrexate for primary central nervous system lymphoma (PCNSL).
Bergner N; Monsef I; Illerhaus G; Engert A; Skoetz N
Cochrane Database Syst Rev; 2012 Nov; 11():CD009355. PubMed ID: 23152274
[TBL] [Abstract][Full Text] [Related]
8. Systemic immune-inflammation index, neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio can predict clinical outcomes in patients with metastatic non-small-cell lung cancer treated with nivolumab.
Liu J; Li S; Zhang S; Liu Y; Ma L; Zhu J; Xin Y; Wang Y; Yang C; Cheng Y
J Clin Lab Anal; 2019 Oct; 33(8):e22964. PubMed ID: 31282096
[TBL] [Abstract][Full Text] [Related]
9. A new prognostic score for disease progression and mortality in patients with newly diagnosed primary CNS lymphoma.
Liu CJ; Lin SY; Yang CF; Yeh CM; Kuan AS; Wang HY; Tsai CK; Gau JP; Hsiao LT; Chen PM; Liu YC; Hong YC; Ko PS; Liu JH; Lin CH
Cancer Med; 2020 Mar; 9(6):2134-2145. PubMed ID: 32011103
[TBL] [Abstract][Full Text] [Related]
10. The Prognostic Value of Blood-Based Biomarkers in Patients With Testicular Diffuse Large B-Cell Lymphoma.
Yang J; Guo X; Hao J; Dong Y; Zhang T; Ma X
Front Oncol; 2019; 9():1392. PubMed ID: 31921649
[No Abstract] [Full Text] [Related]
11. A novel inflammation-related prognostic model for predicting the overall survival of primary central nervous system lymphoma: A real-world data analysis.
Wu Z; Wang C; Lyu Y; Lin Z; Lu M; Wang S; Wang B; Yang N; Li Y; Wang J; Duan X; Zhang N; Gao J; Zhang Y; Hao M; Wang Z; Gao G; Liang R
Front Oncol; 2023; 13():1104425. PubMed ID: 37056341
[TBL] [Abstract][Full Text] [Related]
12. A Prognostic Model Using Post-Steroid Neutrophil-Lymphocyte Ratio Predicts Overall Survival in Primary Central Nervous System Lymphoma.
Lo YT; Lim VY; Ng M; Tan YH; Chiang J; Chang EWY; Chan JY; Poon EYL; Somasundaram N; Bin Harunal Rashid MF; Tao M; Lim ST; Yang VS
Cancers (Basel); 2022 Apr; 14(7):. PubMed ID: 35406590
[TBL] [Abstract][Full Text] [Related]
13. Prognostic role of the neutrophil-to-lymphocyte ratio in patients with primary central nervous system lymphoma.
Jung J; Lee H; Yun T; Lee E; Moon H; Joo J; Park WS; Choi M; Lee JO; Lee JS; Eom HS
Oncotarget; 2017 Sep; 8(43):74975-74986. PubMed ID: 29088839
[TBL] [Abstract][Full Text] [Related]
14. The Impacts of Systemic Immune-Inflammation Index on Clinical Outcomes in Gallbladder Carcinoma.
Sun L; Jin Y; Hu W; Zhang M; Jin B; Xu H; Du S; Xu Y; Zhao H; Lu X; Sang X; Zhong S; Yang H; Mao Y
Front Oncol; 2020; 10():554521. PubMed ID: 33194617
[No Abstract] [Full Text] [Related]
15. Systemic Immune-Inflammation Index and Changes of Neutrophil-Lymphocyte Ratio as Prognostic Biomarkers for Patients With Pancreatic Cancer Treated With Immune Checkpoint Blockade.
Shang J; Han X; Zha H; Tao H; Li X; Yuan F; Chen G; Wang L; Ma J; Hu Y
Front Oncol; 2021; 11():585271. PubMed ID: 33718140
[TBL] [Abstract][Full Text] [Related]
16. Prognostic meaning of neutrophil to lymphocyte ratio (NLR) and lymphocyte to monocyte ration (LMR) in newly diagnosed Hodgkin lymphoma patients treated upfront with a PET-2 based strategy.
Romano A; Parrinello NL; Vetro C; Chiarenza A; Cerchione C; Ippolito M; Palumbo GA; Di Raimondo F
Ann Hematol; 2018 Jun; 97(6):1009-1018. PubMed ID: 29442162
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of the Nordic and the MSKCC chemotherapy protocols on the overall and progression-free survival in intracranial PCNSL.
Da Broi M; Jahr G; Beiske K; Holte H; Meling TR
Blood Cells Mol Dis; 2018 Nov; 73():25-32. PubMed ID: 30217760
[TBL] [Abstract][Full Text] [Related]
18. Pretreatment Lymphocyte to Monocyte Ratio is an Independent Prognostic Factor in Metastatic Clear Cell Renal Cell Carcinoma.
Gu L; Ma X; Xie Y; Li H; Wang L; Chen L; Zhao W; Zhang Y; Zhang X
Clin Genitourin Cancer; 2017 Jun; 15(3):e369-e377. PubMed ID: 28038932
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of Memorial Sloan-Kettering Cancer Center and International Extranodal Lymphoma Study Group prognostic scoring systems to predict Overall Survival in intracranial Primary CNS lymphoma.
Jahr G; Broi MD; Holte H; Beiske K; Meling TR
Brain Behav; 2018 Mar; 8(3):e00928. PubMed ID: 29541540
[TBL] [Abstract][Full Text] [Related]
20. Pretreatment inflammatory indexes as prognostic predictors for survival in osteosarcoma patients.
Yang S; Wu C; Wang L; Shan D; Chen B
Int J Clin Exp Pathol; 2020; 13(3):515-524. PubMed ID: 32269690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
